ScholarLens Back to search
2007•Health Medicine Research and PracticeRequires access

The Effect of Losartan on Proteinuria in the Patients With Diabetic Nephropathy

Shue Wang

Open publisher page 0 citations

Abstract

Objective To observe the effect of Losartan on proteinuria in the patients with diabetic nephropathy. Method 42 patients with type II diabetes mellitus patients in early-stage diabetic nephropathy were conducted into two groups. 23 patients were treated with losartan, 50 mg per day for 24 weeks,19 patients in control group. Results In treating group, proteinuria were significantly reduced from 116±81 μg/min to 50±38 μg/min(p0.05) as compared with the control group(p0.05). Conclusion Losartan is an effective and safe drug for treating early-stage diadetic nephropathy.

About this research paper

What this paper is about

Objective To observe the effect of Losartan on proteinuria in the patients with diabetic nephropathy. Method 42 patients with type II diabetes mellitus patients in early-stage diabetic nephropathy were conducted into two groups. 23 patients were treated with losartan, 50 mg per day for 24 weeks,19 patients in control group. Results In treating group, proteinuria were significantly reduced from 116±81 μg/min to 50±38 μg/min(p0.05) as compared with the control group(p0.05). Conclusion Losartan is an effective and safe drug for treating early-stage diadetic nephropathy.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To observe the effect of Losartan on proteinuria in the patients with diabetic nephropathy. Method 42 patients with type II diabetes mellitus patients in early-stage diabetic nephropathy were conducted into two groups. 23 patients were treated with losartan, 50 mg per day for 24 weeks,19 patients in control group. Results In treating group, proteinuria were significantly reduced from 116±81 μg/min to 50±38 μg/min(p0.05) as compared with the control group(p0.05). Conclusion Losartan is an effective and safe drug for treating early-stage diadetic nephropathy.

Key concepts: Losartan, Proteinuria, Medicine, Diabetic nephropathy, Nephropathy, Diabetes mellitus, Urology, Internal medicine

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
The Effect of Losartan on Proteinuria in the Patients With Diabetic Nephropathy — Research Paper | ScholarLens